Adjuvant chemoradiotherapy after D2 resection in gastric cancer: a single-center observational study.

Saglam, Esra; YÜCEL, Serap; Balik, Emre; Saglam, Sezer; Asoglu, Oktar; YAMANER, Sumer; Bugra, Dursun; Oral, Ethem; Kizir, Ahmet; Kapran, Yersu; Sakar, Burak; Akyuz, Ali; Gulluoglu, Mine

doi:10.1007/s00432-014-1816-y

Adjuvant chemoradiotherapy after D2 resection in gastric cancer: a single-center observational study.

Atıf İçin Kopyala

Saglam E. K., YÜCEL S., Balik E., Saglam S., Asoglu O., YAMANER S., ...Daha Fazla

Journal of cancer research and clinical oncology, cilt.141, sa.2, ss.361-7, 2015 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 141 Sayı: 2
Basım Tarihi: 2015
Doi Numarası: 10.1007/s00432-014-1816-y
Dergi Adı: Journal of cancer research and clinical oncology
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.361-7
Anahtar Kelimeler: Adjuvant therapy, Chemoradiotherapy, Gastric cancer, D2 resection, PHASE-III TRIAL, NODAL DISSECTION, STOMACH-CANCER, CHEMOTHERAPY, ADENOCARCINOMA, RADIOTHERAPY, PATTERNS, SURGERY, CAPECITABINE, GASTRECTOMY
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Previous studies demonstrated survival benefits in association with the addition of chemoradiotherapy after surgery in gastric cancer. This study aimed to examine the efficacy in terms of loco-regional control and survival and safety of 5-FU-based adjuvant chemoradiotherapy after D2 curative surgery.